The major purpose of this clinical study is to assess clinical outcome of dose-adjusted EPOCH
regimen for patients with non-Hodgkin's lymphoma(NHL)-associated hemophagocytic
lymphohistiocytosis
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University